Fernández-González Loreto, Quezada Constanza, Turén Valentina, Bravo Paulina
Instituto Oncológico Fundación Arturo López Pérez, Providencia, Chile.
Psychooncology. 2025 Apr;34(4):e70138. doi: 10.1002/pon.70138.
Breast cancer (BC) is the leading cause of cancer deaths among Chilean women. BC treatment is guaranteed by Chilean law through the Explicit Health Guarantees (GES) plan. There is insufficient evidence on how women navigate the healthcare system and how they exercise shared decision-making (SDM) following a BC diagnosis in global South scenarios.
To understand how women make decisions about BC treatment.
A qualitative study based on 29 individual, semi-structured, in-depth interviews with women undergoing BC treatment in three hospitals in Santiago. Recruitment took place from November 2022 until July 2023. Thematic analysis was performed with AtlasTi.
The experience that care is not happening quickly enough organizes the trajectory of BC patients under the major, in vivo theme of "Everything is slow." Managing this wait mobilizes women through clinical milestones, configuring high or low participation scenarios. Scenarios of high participation comprised decisions mostly regarding practical issues, financial and insurance decisions and whatever actions could be taken to shorten waiting times. Scenarios of low-experienced participation coincided with clinical encounters with health professionals, with treatment decisions delegated to or exclusively made by clinicians.
BC is experienced as a distressing diagnosis. Women prioritize decisions that they perceive will speed up their care and do not effectively participate in treatment decision-making. This study is part of a larger mixed-methods project that aims to elucidate factors influencing SDM in BC. Future directions should provide strategies to patients and clinicians to build more symmetrical relationships and evaluate the satisfaction with care of universal coverage-oriented policies, as well as how this could influence the exercise of patients' autonomy.
乳腺癌(BC)是智利女性癌症死亡的主要原因。智利法律通过明确健康保障(GES)计划保障乳腺癌治疗。在全球南方的情况下,关于女性如何在医疗保健系统中就医以及在乳腺癌诊断后如何进行共同决策(SDM)的证据不足。
了解女性如何做出乳腺癌治疗决策。
一项定性研究,基于对圣地亚哥三家医院接受乳腺癌治疗的女性进行的29次个人、半结构化、深入访谈。招募工作于2022年11月至2023年7月进行。使用AtlasTi进行主题分析。
“一切都很缓慢”这一主要的、实际存在的主题下,认为护理速度不够快的体验构成了乳腺癌患者的就医轨迹。应对这种等待通过临床节点调动女性,形成高参与度或低参与度的情形。高参与度情形主要包括关于实际问题、财务和保险决策以及任何可采取的缩短等待时间的行动的决策。低参与度情形则与与医疗专业人员的临床接触相吻合,治疗决策由临床医生委托或完全由临床医生做出。
乳腺癌被视为令人痛苦的诊断。女性优先考虑她们认为会加快护理速度的决策,而没有有效地参与治疗决策。本研究是一个更大的混合方法项目的一部分,该项目旨在阐明影响乳腺癌共同决策的因素。未来的方向应该为患者和临床医生提供策略,以建立更对称的关系,并评估对以全民覆盖为导向的政策的护理满意度,以及这如何影响患者自主权的行使。